Alector to Participate in Upcoming Healthcare Conferences
Alector (NASDAQ: ALEC), a late-stage clinical biotechnology company specializing in neurodegeneration therapies, has announced its participation in two upcoming healthcare investor conferences. The company will deliver a corporate presentation at the Bank of America Securities Health Care Conference in Las Vegas on May 13, 2025, at 2:20 p.m. PT. Additionally, Alector will participate in a fireside chat at the H.C. Wainwright 3rd Annual BioConnect Investor Conference in New York on May 20, 2025, at 12:00 p.m. ET. Both presentations will be available via webcast on Alector's investor relations website, with replays accessible for 90 days following the events.
Alector (NASDAQ: ALEC), una società biotecnologica in fase avanzata specializzata in terapie per le neurodegenerazioni, ha annunciato la sua partecipazione a due prossime conferenze per investitori nel settore sanitario. L'azienda terrà una presentazione aziendale al Bank of America Securities Health Care Conference a Las Vegas il 13 maggio 2025 alle 14:20 PT. Inoltre, Alector parteciperà a una discussione informale al H.C. Wainwright 3rd Annual BioConnect Investor Conference a New York il 20 maggio 2025 alle 12:00 ET. Entrambe le presentazioni saranno disponibili in webcast sul sito web delle relazioni con gli investitori di Alector, con repliche accessibili per 90 giorni dopo gli eventi.
Alector (NASDAQ: ALEC), una empresa biotecnológica en etapa avanzada especializada en terapias para la neurodegeneración, ha anunciado su participación en dos próximas conferencias para inversores en salud. La compañía realizará una presentación corporativa en la Bank of America Securities Health Care Conference en Las Vegas el 13 de mayo de 2025 a las 2:20 p.m. PT. Además, Alector participará en una charla informal en la H.C. Wainwright 3rd Annual BioConnect Investor Conference en Nueva York el 20 de mayo de 2025 a las 12:00 p.m. ET. Ambas presentaciones estarán disponibles vía webcast en el sitio web de relaciones con inversores de Alector, con repeticiones accesibles durante 90 días después de los eventos.
Alector (NASDAQ: ALEC)는 신경퇴행성 질환 치료제 개발에 특화된 후기 임상 단계의 생명공학 기업으로, 다가오는 두 개의 헬스케어 투자자 컨퍼런스에 참여할 예정임을 발표했습니다. 회사는 2025년 5월 13일 오후 2시 20분(태평양 시간)에 라스베이거스에서 열리는 Bank of America Securities Health Care Conference에서 기업 발표를 진행합니다. 또한, 2025년 5월 20일 정오(동부 시간) 뉴욕에서 개최되는 H.C. Wainwright 3rd Annual BioConnect Investor Conference에서 파이어사이드 채팅에 참여할 예정입니다. 두 발표 모두 Alector 투자자 관계 웹사이트를 통해 웹캐스트로 제공되며, 행사 종료 후 90일간 다시보기 서비스를 이용할 수 있습니다.
Alector (NASDAQ : ALEC), une société biotechnologique en phase clinique avancée spécialisée dans les thérapies contre la neurodégénérescence, a annoncé sa participation à deux prochaines conférences pour investisseurs dans le secteur de la santé. L'entreprise présentera une conférence d'entreprise lors de la Bank of America Securities Health Care Conference à Las Vegas le 13 mai 2025 à 14h20 PT. De plus, Alector participera à une discussion informelle lors de la H.C. Wainwright 3rd Annual BioConnect Investor Conference à New York le 20 mai 2025 à 12h00 ET. Les deux présentations seront disponibles en webdiffusion sur le site des relations investisseurs d'Alector, avec des rediffusions accessibles pendant 90 jours après les événements.
Alector (NASDAQ: ALEC), ein biotechnologisches Unternehmen in der späten klinischen Phase, das sich auf Therapien gegen Neurodegeneration spezialisiert hat, hat seine Teilnahme an zwei bevorstehenden Investorenkonferenzen im Gesundheitswesen angekündigt. Das Unternehmen wird am 13. Mai 2025 um 14:20 Uhr PT eine Unternehmenspräsentation auf der Bank of America Securities Health Care Conference in Las Vegas halten. Zusätzlich wird Alector am 20. Mai 2025 um 12:00 Uhr ET an einem Fireside-Chat auf der H.C. Wainwright 3rd Annual BioConnect Investor Conference in New York teilnehmen. Beide Präsentationen werden per Webcast auf der Investor-Relations-Website von Alector verfügbar sein, wobei Wiederholungen 90 Tage nach den Veranstaltungen abrufbar sind.
- None.
- None.
SOUTH SAN FRANCISCO, Calif., May 06, 2025 (GLOBE NEWSWIRE) -- Alector, Inc. (Nasdaq: ALEC), a late-stage clinical biotechnology company focused on developing therapies to counteract the devastating progression of neurodegeneration, today announced that management will participate in the following upcoming investor conferences:
- Bank of America Securities Health Care Conference (Las Vegas, Nevada)
- Tuesday, May 13, 2025, at 2:20 p.m. PT, corporate presentation
- H.C. Wainwright 3rd Annual BioConnect Investor Conference (New York, New York)
- Tuesday, May 20, 2025, at 12:00 p.m. ET, fireside chat
A webcast of each conference presentation will be available on the “Events & Presentations” page within the Investors section of the Alector website at http://investors.alector.com. Replays of the webcasts will be available on the Alector website for 90 days following the presentation dates.
About Alector
Alector is a late-stage clinical biotechnology company focused on developing therapies to counteract the devastating progression of neurodegenerative diseases. Leveraging the principles of genetics, immunology, and neuroscience, the company is advancing a portfolio of genetically validated programs that aim to remove toxic proteins, replace deficient proteins, and restore immune and nerve cell function. Supported by biomarkers, Alector’s product candidates seek to treat a range of indications, such as frontotemporal dementia, Alzheimer’s disease, and Parkinson's disease. The company is also developing Alector Brain Carrier (ABC), a proprietary blood-brain barrier platform, which is being selectively applied to its next-generation product candidates and research pipeline. ABC aims to enhance the delivery of therapeutics, achieve deeper brain penetration and efficacy at lower doses, and ultimately improve patient outcomes while reducing costs. Alector is headquartered in South San Francisco, California. For more information, please visit www.alector.com.
Alector Contacts:
Alector
Katie Hogan
202-549-0557
katie.hogan@alector.com
Argot Partners (media)
David Rosen
646-461-6387
alector@argotpartners.com
Argot Partners (investors)
Laura Perry
212-600-1902
alector@argotpartners.com
FAQ
When is Alector (ALEC) presenting at the Bank of America Securities Health Care Conference 2025?
Where can I watch Alector's (ALEC) investor conference presentations?
What is Alector's (ALEC) main business focus?
When is Alector's (ALEC) fireside chat at the H.C. Wainwright BioConnect Conference?
